Startseite › Übergewicht › Florida › Orlando
Klinische Studien zu Übergewicht in Orlando, FL
27 Studien zu Übergewicht suchen Teilnehmer an Standorten in und um Orlando (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Teilnehmer gesuchtPhase 2
- Charter Research - Winter Park /ID# 281968, Orlando
- Florida Institute For Clinical Research /ID# 282739, Orlando
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Teilnehmer gesucht
- Orlando Health, Inc., Orlando
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Teilnehmer gesuchtPhase 1Gesunde Freiwillige willkommen
- Kailera Clinical Site, Orlando
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Teilnehmer gesuchtPhase 3
- Florida Institute for Clinical Research, LLC, Orlando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Teilnehmer gesuchtPhase 2
- Clinical Site Partners, LLC DBA Flourish Research, Winter Park · 5 mi entfernt
- K2 Medical Research Maitland LLC, Main Office, Maitland · 6 mi entfernt
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Teilnehmer gesuchtPhase 2
- Clinical Neuroscience Solutions, Orlando
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Teilnehmer gesuchtPhase 3
- Clinical Neuroscience Solution, Orlando
- Florida Institute for Clinical Research, LLC, Orlando
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Teilnehmer gesuchtPhase 3
- Florida Inst For Clin Res LLC, Orlando
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Teilnehmer gesuchtPhase 3
- Headlands Research Orlando, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Teilnehmer gesuchtPhase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Teilnehmer gesuchtPhase 3
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Teilnehmer gesuchtPhase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Teilnehmer gesuchtPhase 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi entfernt
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Teilnehmer gesuchtPhase 3
- Research Site, Ocoee · 10 mi entfernt
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Teilnehmer gesuchtPhase 3
- West Orange Endocrinology, Ocoee · 10 mi entfernt
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Teilnehmer gesuchtPhase 3
- Conquest Research, Winter Park · 5 mi entfernt
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Teilnehmer gesuchtPhase 2
- Charter Research - Winter Park, Orlando
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Teilnehmer gesuchtPhase 3
- AURORA-1 Clinical Site, Winter Park · 5 mi entfernt
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Teilnehmer gesuchtPhase 3
- AURORA-2 Clinical Site, Winter Park · 5 mi entfernt
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Teilnehmer gesucht
- University of Central Florida, Orlando
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Teilnehmer gesuchtPhase 3Gesunde Freiwillige willkommen
- ACCOMPLISH-2 Research Site, Ocoee · 10 mi entfernt
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Teilnehmer gesuchtPhase 2
- Charter Research - Winter Park, Orlando
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Teilnehmer gesuchtPhase 3
- Kailera Clinical Site, Orlando
- Kailera Clinical Site, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Teilnehmer gesuchtPhase 3
- Clinical Neuroscience Solutions - Orlando, Orlando
- Combined Research Orlando Phase I IV, Orlando
- Florida Institute for Clinical Research, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Teilnehmer gesuchtPhase 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · 5 mi entfernt
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Teilnehmer gesuchtPhase 3
- Clinical Neuroscience Solutions, Orlando
- Florida Institute for Clinical Research, Orlando
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Teilnehmer gesuchtPhase 3
- ACCOMPLISH-1 Research Site, Ocoee · 10 mi entfernt
Übergewicht-Studien in anderen Städten
- San Antonio, TX34 Studien
- Houston, TX33 Studien
- Chicago, IL28 Studien
- Las Vegas, NV23 Studien
- Miami, FL23 Studien
- Atlanta, GA20 Studien
- Dallas, TX20 Studien
- New York City, NY19 Studien
- Jacksonville, FL19 Studien
- Washington, DC19 Studien
- Austin, TX18 Studien
- Baltimore, MD17 Studien
Weitere Studien in Orlando
- Nichtkleinzelliges Lungenkarzinom44 Studien
- Adipositas31 Studien
- Metastasierender Krebs29 Studien
- Alzheimer-Krankheit25 Studien
- Typ-2-Diabetes24 Studien
- Krebs (alle Arten)24 Studien
- Brustkrebs23 Studien
- Eierstockkrebs22 Studien
- Colitis ulcerosa22 Studien
- Lungenkrebs21 Studien
- Kolorektales Karzinom19 Studien
- Major Depression19 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 03.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.